Abstract
This systematic review explored the neurobiological mechanisms underlying the clinical time course of cancer-related cognitive impairment (CRCI) in breast cancer patients through the review of longitudinal neuroimaging studies. Before chemotherapy, results reported no evidence for neuropsychological, structural (gray matter) and brain perfusion changes. However, functional brain alterations were evident and revealed a frontoparietal hyperactivation during working memory tasks. Fatigue and number of days since surgery were the two suggested confounding factors. Acutely after chemotherapy, this review found no evidence for neuropsychological changes while suggesting a pattern of frontal structural, perfusion and functional brain abnormalities. These findings seemed to be dependent on age, menopausal status at baseline, and fMRI task performed. Years after chemotherapy, results revealed evidence of partial neuropsychological, structural, and functional brain recovery. Regarding brain abnormality, this review suggested that it may begin quite early in the disease course, be more prominent shortly after chemotherapy and partially recover over time. Several hypotheses underlying these changes were discussed. The present review also provided important information for developing a time-specific treatment and prevention strategies and for the consideration of functional neuroimaging as a relevant tool for CRCI diagnosis, clinical monitoring, and intervention studies. The findings also suggested the need to implement studies with longitudinal designs, including a pre-treatment assessment, since cross-sectional studies were not able to detect this pattern of recovery over time, supporting only the theory of brain abnormalities, in breast cancer survivors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abraham, J., Haut, M. W., Moran, M. T., Filburn, S., Lemiuex, S., & Kuwabara, H. (2008). Adjuvant chemotherapy for breast cancer: Effects on cerebral white matter seen in diffusion tensor imaging. Clinical Breast Cancer, 8(1), 88–91. https://doi.org/10.3816/CBC.2008.n.007
Ahles, T. A., & Saykin, A. J. (2007). Candidate mechanisms for chemotherapy-induced cognitive changes. Nature Reviews Cancer, 7(3), 192–2011. https://doi.org/10.1038/nrc2073
Ahles, T. A., Saykin, A. J., Noll, W., Furstenberg, C., Guerin, S., Cole, B., & Mott, L. (2003). The relationship of apoe genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psycho-Oncology, 12(6), 612–619. https://doi.org/10.1002/pon.742
Alexopoulos, P., Sorg, C., Förschler, A., Grimmer, T., Skokou, M., Wohlschläger., A., Wohlschläger A., Perneczky R., Zimmer C., Kurz A. Preibisch, C. (2012). Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer’s disease measured by pulsed arterial spin labeling MRI. European Archives of Psychiatry and Clinical Neuroscience, 262(1), 69–77. https://doi.org/10.1007/s00406-011-0226-2.
Ando-Tanabe, N., Iwamitsu, Y., Kuranami, M., Okazaki, S., Yasuda, H., Nakatani, Y., … Miyaoka, H. (2012). Cognitive function in women with breast cancer receiving adjuvant chemotherapy and healthy controls. Breast Cancer, 21(4), 453–462. https://doi.org/10.1007/s12282-012-0405-7
Apple, A. C., Ryals, A. J., Alpert, K. I., Wagner, L. I., Shih, P.-A., Dokucu, M., … Wang, L. (2017). Subtle hippocampal deformities in breast cancer survivors with reduced episodic memory and self-reported cognitive concerns. NeuroImage: Clinical, 14, 685–691. https://doi.org/10.1016/j.nicl.2017.03.004
Askren, M. K., Jung, M., Berman, M. G., Zhang, M., Therrien, B., Peltier, S., … Cimprich, B. (2014). Neuromarkers of fatigue and cognitive complaints following chemotherapy for breast cancer: A prospective fMRI investigation. Breast Cancer Research and Treatment, 147(2), 445–455. https://doi.org/10.1007/s10549-014-3092-6
Assaf, Y., & Pasternak, O. (2008). Diffusion tensor imaging (DTI)-based white matter mapping in brain research: A review. Journal of Molecular Neuroscience, 34(1), 51–61. https://doi.org/10.1007/s12031-007-0029-0
Bender, C. M., Sereika, S. M., Berga, S. L., Vogel, V. G., Brufsky, A. M., Paraska, K. K., & Ryan, C. M. (2006). Cognitive impairment associated with adjuvant therapy in breast cancer. Psychooncology, 15(5), 422–430. https://doi.org/10.1002/pon.964
Bergouignan, L., Lefranc, J. P., Chupin, M., Morel, N., Spano, J. P., & Fossati, P. (2011). Breast cancer affects both the hippocampus volume and the episodic autobiographical memory retrieval. PLoS One, 6(10), e25349. https://doi.org/10.1371/journal.pone.0025349
Berman, M. G., Askren, M. K., Jung, M., Therrien, B., Peltier, S., Noll, D. C., … Cimprich, B. (2014). Pretreatment worry and neurocognitive responses in women with breast cancer. Health Psychology, 33(3), 222–231. https://doi.org/10.1037/a0033425
Biglia, N., Torta, D. M. E., Sismondi, P., & Torta, R. (2011). Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: A prospective study. European Journal of Cancer Care, 21(4), 485–492. https://doi.org/10.1111/j.1365-2354.2011.01320.x
Billiet, T., Emsell, L., Vandenbulcke, M., Peeters, R., Christiaens, D., Leemans, A., … Deprez, S. (2018). Recovery from chemotherapy-induced white matter changes in young breast cancer survivors? Brain Imaging and Behavior, 12(1), 64–77. https://doi.org/10.1007/s11682-016-9665-8
Boykoff, N., Moieni, M., & Subramanian, S. K. (2009). Confronting chemobrain: An in-depth look at survivors’ reports of impact on work, social networks, and health care response. Journal of Cancer Survivorship, 3(4), 223–232. https://doi.org/10.1007/s11764-009-0098-x
Brezden, B., Phillips, K., Abdolell, M., Bunston, T., & Tannock, I. F. (2000). Cognitive function in breast cancer patients receiving adjuvant chemotherapy. Journal of Clinical Oncology, 18(14), 2695–2701. https://doi.org/10.1200/JCO.2000.18.14.2695
Briones, T. L., & Woods, J. (2014). Immunity dysregulation in myelination mediated by persistent neuroinflammation: Possible mechanisms in chemotherapy-related cognitive. Brain Behavior Immunity, 35, 23–32. https://doi.org/10.1016/j.bbi.2013.07.175
Campbell, K. L., Kam, J. W., Neil-Sztramko, S. E., Ambrose, T. L., Handy, T. C., Li, H. J., … Boyd, L. A. (2018). Effect of aerobic exercise on cancer-associated cognitive impairment: A proof-of-concept RCT. Psychooncology, 27(1), 53–60. https://doi.org/10.1002/pon.4370
Castellon, S., & Ganz, P. A. (2009). Neuropsychological studies in breast cancer: In search of chemobrain. Breast Cancer Research and Treatment, 116(1), 125–127. https://doi.org/10.1007/s10549-008-0211-2
Castellon, S. A., Ganz, P. A., Bower, J. E., Petersen, L., Abraham, L., & Greendale, G. A. (2004). Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. Journal of Clinical and Experimental Neuropsychology, 26(7), 955–969. https://doi.org/10.1080/13803390490510905
Chen, B. T., Jin, T., Patel, S. K., Ye, N., Lan, C., Huiyan, S., … Hurria, A. (2018a). Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer. Breast Cancer Research and Treatment, 172(2), 363–370. https://doi.org/10.1007/s10549-018-4911-y
Chen, B. T., Sethi, S. K., Jin, T., Patel, S. K., Ye, N., Sun, C., … Tan, H. (2018b). Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: A brain magnetic resonance imaging pilot study. Breast Cancer Research, 20(1), 1–11. https://doi.org/10.1186/s13058-018-0965-3
Chiesa, A., Calati, R., & Serretti, A. (2011). Clinical psychology review does mindfulness training improve cognitive abilities? A systematic review of neuropsychological findings. Clinical Psychology Review, 31(3), 449–464. https://doi.org/10.1016/j.cpr.2010.11.003
Churchill, N. W., Cimprich, B., Askren, M. K., Reuter-lorenz, P. A., Jung, M. S., Peltier, S., & Berman, M. G. (2015). Scale-free brain dynamics under physical and psychological distress: Pre-treatment effects in women diagnosed with breast cancer. Human Brain Mapping, 36(3), 1077–1092. https://doi.org/10.1002/hbm.22687
Cimprich, B., Reuter-Lorenz, P., Nelson, J., Clark, P. M., Therrien, B., Normolle, D., … Welsh, R. C. (2010). Prechemotherapy alterations in brain function in women with breast cancer. Journal of Clinical and Experimental Neuropsychology, 32(3), 324–331. https://doi.org/10.1080/13803390903032537
Cimprich, B., So, H., Ronis, D., & Trask, C. (2005). Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer. Psycho-Oncology, 14(1), 70–78. https://doi.org/10.1002/pon.821
Collins, B., Mackenzie, J., Tasca, G. A., Scherling, C., & Smith, A. (2012). Cognitive effects of chemotherapy in breast cancer patients: A dose – Response study. Psychooncology, 22(7), 1517–1527. https://doi.org/10.1002/pon.3163
Conroy, S. K., McDonald, B., Ahles, T. A., West, J., & Saykin, J. (2013a). Chemotherapy-induced amenorrhea: A prospective study of brain activation changes and neurocognitive correlates. Brain Imaging and Behavior, 7(4), 491–500. https://doi.org/10.1007/s11682-013-9240-5
Conroy, S. K., McDonald, B. C., Smith, D. J., Moser, L. R., West, J. D., Kamendulis, L. M., … Saykin, A. J. (2013b). Alterations in brain structure and function in breast cancer survivors: Effect of post-chemotherapy interval and relation to oxidative DNA damage. Breast Cancer Research and Treatment, 137(2), 493–502. https://doi.org/10.1007/s10549-012-2385-x
Cremers, H. R., Wager, T. D., & Yarkoni, T. (2017). The relation between statistical power and inference in fMRI. PLoS One, 12(11), e0184923. https://doi.org/10.1371/journal.pone.0184923
Debess, J., Riis, J. S., Pedersen, L., & Ewertz, M. (2009). Cognitive function and quality of life after surgery for early breast cancer in North Jutland, Denmark. Acta Oncologica, 48(4), 532–541. https://doi.org/10.1080/02841860802600755
Delinger, C. S., Ligibel, J. A., Are, M., Baker, K. S., Broderick, G., Demark-Wahnefried, W., … Freedman-Cass, D. A. (2016). NCCN guidelines. Insights survivorship, version 1.2016. Featured updates to the NCCN guidelines. Journal of the National Comprehensive Cancer Network, 14(6), 715–724. https://doi.org/10.6004/jnccn.2016.0073
Deprez, S., Amant, F., Smeets, A., Peeters, R., Leeman, A., Van Hecke, W., … Sunaert, S. (2012). Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. Journal of Clinical Oncology, 30(3), 274–281. https://doi.org/10.1200/JCO.2011.36.8571
Deprez, S., Amant, F., Yigit, R., Porke, K., Verhoeven, J., Van den Stock, J., … Sunaert, S. (2011). Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Human Brain Mapping, 32(3), 480–493. https://doi.org/10.1002/hbm.21033
Deprez, S., Kesler, S. R., Saykin, A. J., Silverman, D. H. S., De Ruiter, M. B., & McDonald, B. C. (2018). International cognition and Cancer task force recommendations for neuroimaging methods in the study of cognitive impairment in non-CNS cancer patients. Journal of the National Cancer Institute, 110(3), 223–231. https://doi.org/10.1093/jnci/djx285
Deprez, S., Vandenbulcke, M., Peeters, R., Emsell, L., Smeets, A., Christiaens, M., … Sunaert, S. (2014). Longitudinal assessment of chemotherapy-induced alterations in brain activation during multitasking and its relation with cognitive complaints. Journal of Clinical Oncology, 32(19), 2031–2038. https://doi.org/10.1200/JCO.2013.53.6219
Dijkers, M. (2018). Duplicate publications and systematic reviews: Problems and proposals. KT Update, 6 (2). Retrieved from https://ktdrr.org/products/update/v6n2/dijkers_ktupdate_v6n2-508.pdf.
Dumas, J. A., Makarewicz, J., Schaubhut, G. J., Devins, R., Albert, K., Dittus, K., & Newhouse, P. A. (2013). Chemotherapy altered brain functional connectivity in women with breast cancer: A pilot study. Brain Imaging and Behavior, 7(4), 524–532. https://doi.org/10.1007/s11682-013-9244-1
Ehlers, D. K., Aguiñaga, S., Cosman, J., Severson, J., Kramer, A. F., & McAuley, E. (2017). The effects of physical activity and fatigue on cognitive performance in breast cancer survivors. Breast Cancer Research and Treatment, 165(3), 699–707. https://doi.org/10.1007/s10549-017-4363-9
Frank, J. S., Vance, D. E., Triebel, K. L., & Meneses, K. M. (2015). Cognitive deficits in breast cancer survivors after chemotherapy and hormonal therapy. Journal of Neuroscience Nursing, 47(6), 302–312. https://doi.org/10.1097/JNN.0000000000000171
Ferguson, R. J., McDonald, B. C., Saykin, A. J., & Ahles, T. A. (2007). Brain structure and function differences in monozygotic twins: Possible effects of breast cancer chemotherapy. Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 25(25), 3866–3870. https://doi.org/10.1200/JCO.2007.10.8639
Ganz, P. A., Kwan, L., Castellon, S. A., Oppenheim, A., Bower, J. E., Silverman, D. H. S., … Belin, T. R. (2013). Cognitive complaints after breast cancer treatments : Examining the relationship with neuropsychological test performance. Journal of the National Cancer Institute, 105(11), 791–801. https://doi.org/10.1093/jnci/djt073
Gentry, A. L., Sereika, S. M., Casillo, F. E., Crisafio, E., Donahue, P. T., Grove, G. A., … Bender, C. M. (2018). Protocol for exercise program in Cancer and cognition (EPICC): A randomized controlled trial of the effects of aerobic exercise on cognitive function in postmenopausal women with breast cancer receiving aromatase inhibitor therapy. Contemporary Clinical Trials, 67, 109–115. https://doi.org/10.1016/j.cct.2018.02.012
Haller, S., Zaharchuk, G., Thomas, D. L., Lovblad, K., Barkhof, F., & Golay, X. (2016). Arterial spin labeling perfusion of the brain: Emerging clinical. Radiology, 281(2), 337–356. https://doi.org/10.1148/radiol.2016150789
Hermelink, K., Ku, H., Untch, M., Bauerfeind, I., Lux, M. P., Bu, M., … Mu, K. (2010). Two different sides of “chemobrain”: Determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study. Psychooncology, 19(12), 1321–1328. https://doi.org/10.1002/pon.1695
Higgins, J. P. T., & Green, S. (Eds.). (2008). Cochrane handbook for systematic reviews of interventions. Chichester: John Wiley & Sons, Ltd. Retrieved fromhttps://pdfs.semanticscholar.org/4b43/91c08c45ebfcd046a53106c97ca09fcdf9fa.pdf.
Inagaki, M., Yoshikawa, E., Matsuoka, Y., Sugawara, Y., Nakano, T., Akechi, T., … Uchitomi, Y. (2007). Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer, 109(1), 146–156. https://doi.org/10.1002/cncr.22368
Janelsins, M. C., Heckler, C. E., Peppone, L. J., Kamen, C., Mustian, K. M., Mohile, S. G., … Morrow, G. R. (2017). Cognitive complaints in survivors of breast cancer after chemotherapy compared with age-matched controls: An analysis from a nationwide, multicenter, prospective longitudinal study. Journal of Clinical Oncology, 35(5), 506–514. https://doi.org/10.1200/JCO.2016.68.5826
Jenkins, V., Thwaites, R., Cercignani, M., Sacre, S., Harrison, N., Jones, H. W., … Harder, H. (2016). A feasibility study exploring the role of pre-operative assessment when examining the mechanism of “chemo-brain” in breast cancer patients. SpringerPlus, 5(1), 390. https://doi.org/10.1186/s40064-016-2030-y
Jung, M. S., Zhang, M., Askren, M. K., Berman, M. G., Peltier, S., Hayes, D. F., … Cimprich, B. (2017). Cognitive dysfunction and symptom burden in women treated for breast cancer: A prospective behavioral and fMRI analysis. Brain Imaging and Behavior, 11(1), 86–99. https://doi.org/10.1007/s11682-016-9507-8
Kesler, S., Janelsins, M., Koovakkattu, D., Palesh, O., Mustian, K., Morrow, G., & Dhabhar, F. (2013). Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain, Behavior and Immunity, 30, 109–S116. https://doi.org/10.1016/j.bbi.2012.05.017
Kesler, S. R., Adams, M., Packer, M., Rao, V., Henneghan, A. M., Blayney, D. W., & Palesh, O. (2017a). Disrupted brain network functional dynamics and hyper-correlation of structural and functional connectome topology in patients with breast cancer prior to treatment. Brain and Behavior, 7(3), e00643. https://doi.org/10.1002/brb3.643
Kesler, S. R., Kent, J. S., & O’Hara, R. (2011). Prefrontal cortex and executive function impairments in primary breast cancer. Archives of Neurology, 68(11), 1447–1453. https://doi.org/10.1001/archneurol.2011.245
Kesler, S. R., Rao, A., Blayney, D. W., Oakley-Girvan, I. A., Karuturi, M., & Palesh, O. (2017b). Predicting long-term cognitive outcome following breast cancer with pre-treatment resting state fmri and random forest machine learning. Frontiers in Human Neuroscience, 11. https://doi.org/10.3389/fnhum.2017.00555
Kesler, S. R., Watson, C. L., & Blayney, D. W. (2015). Brain network alterations and vulnerability to simulated neurodegeneration in breast cancer. Neurobiology of Aging, 36(8), 2429–2942. https://doi.org/10.1016/j.neurobiolaging.2015.04.015
Klemp, J. R., Myers, J. S., Fabian, C. J., Kimler, B. F., Khan, Q. J., Sereika, S. M., & Stanton, A. L. (2018). Cognitive functioning and quality of life following chemotherapy in pre- and peri-menopausal women with breast cancer. Supportive Care Cancer, 26(2), 575–583. https://doi.org/10.1007/s00520-017-3869-3
Koppelmans, V., Breteler, M. M. B., Boogerd, W., Seynaeve, C., & Gundy, C. (2012a). Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. Journal of Clinical Oncology, 30(10), 1099–1106. https://doi.org/10.1200/JCO.2011.37.0189
Koppelmans, V., De Ruiter, M. B., & Van Der Lijn, F. (2012b). Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy. Breast Cancer Research and Treatment, 132(3), 1099–1106. https://doi.org/10.1007/s10549-011-1888-1
Lange, M., Allouache, D., Kurtz, J., Heutte, N., Le, C., Rieux, C., … Joly, F. (2014). Baseline cognitive functions among elderly patients with localised breast cancer. European Journal of Cancer, 50(13), 2181–2189. https://doi.org/10.1016/j.ejca.2014.05.026
Lepage, C., Smith, A. M., Moreau, J., Barlow-Krelina, E., Wallis, N., Collins, B., … Scherling, C. (2014). A prospective study of grey matter and cognitive function alterations in chemotherapy-treated breast cancer patients. SpringerPlus, 3(1). https://doi.org/10.1186/2193-1801-3-444
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., … Moher, D. (2009). The PRISMA statement for reporting systematic reviews andmeta-analyses of studies that evaluate health care interventions: Explanation and elaboration. Journal of Clinical Epidemiology, 62, 1–34. https://doi.org/10.1136/bmj.b2700
McDonald, B. C., Conroy, S. K., Ahles, T. A., West, J., & Saykin, A. (2010). Gray matter reduction associated with systemic chemotherapy for breast cancer: A prospective MRI study. Breast Cancer Research and Treatment, 123(3), 819–828. https://doi.org/10.1007/s10549-010-1088-4
McDonald, B. C., Conroy, S. K., Ahles, T. A., West, J. D., Saykin, A. J., Mcdonald, B. C., & Conroy, S. K. (2012). Alterations in brain activation during working memory processing associated with breast cancer and treatment: A prospective functional magnetic resonance imaging study. Journal of Clinical Oncology, 30(20), 2500–2508. https://doi.org/10.1200/JCO.2011.38.5674
McDonald, B. C., Conroy, S. K., Smith, D. J., West, J. D., & Saykin, A. J. (2013). Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: A replication and extension study. Brain, Behavior, and Immunity, 30, 117–125. https://doi.org/10.1016/j.bbi.2012.05.007
Menning, S., de Ruiter, M. B., Veltman, D. J., Boogerd, W., Oldenburg, H. S. A., Reneman, L., & Schagen, S. B. (2017). Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type. PLoS One, 12(3), e0171724. https://doi.org/10.1371/journal.pone.0171724
Menning, S., de Ruiter, M. B., Veltman, D. J., Boogerd, W., Oldenburg, H. S. A., Reneman, L., & Schagen, S. B. (2018). Changes in brain white matter integrity after systemic treatment for breast cancer: A prospective longitudinal study. Brain Imaging and Behavior, 12(2), 324–334. https://doi.org/10.1007/s11682-017-9695-x
Menning, S., de Ruiter, M. B., Veltman, D. J., Koppelmans, V., Kirschbaum, C., Boogerd, W., … Schagen, S. B. (2015). Multimodal MRI and cognitive function in patients with breast cancer prior to adjuvant treatment--the role of fatigue. NeuroImage. Clinical, 7, 547–554. https://doi.org/10.1016/j.nicl.2015.02.005
Miao, H., Li, J., Hu, S., He, X., Partridge, S. C., Ren, J., … Qiu, B. (2016). Long-term cognitive impairment of breast cancer patients after chemotherapy: A functional MRI study. European Journal of Radiology, 85(6), 1053–1057. https://doi.org/10.1016/j.ejrad.2016.03.011
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Annals of Internal Medicine, 151(4), 264–269. https://doi.org/10.7326/0003-4819-151-4-200908180-00135
Morrow, G. R. (2007). Cancer-related fatigue: Causes, consequences, and management. The Oncologist, 12(1), 1–3. https://doi.org/10.1634/theoncologist.12-S1-1
Munn, Z., Moola, S., Riitano, D., & Lisy, K. (2014). The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. International Journal of Health Policy and Management, 3(3), 123–128. https://doi.org/10.15171/ijhpm.2014.71
Nudelman, K. N. H., Wang, Y., McDonald, B. C., Conroy, S. K., Smith, D. J., West, J. D., … Saykin, A. J. (2014). Altered cerebral blood flow one month after systemic chemotherapy for breast cancer: A prospective study using pulsed arterial spin labeling MRI perfusion. PLoS One, 9(5), e96713. https://doi.org/10.1371/journal.pone.0096713
Pullens, M. J. J., De Vries, J., & Roukema, J. A. (2010). Subjective cognitive dysfunction in breast cancer patients: A systematic review. Psychooncology, 19(11), 1127–1138. https://doi.org/10.1002/pon.1673
Raudonis, B., Kelley, I. H., Rowe, N., & Ellis, J. (2017). A pilot study of proinflammatory cytokines and fatigue in women with breast cancer during chemotherapy. Cancer Nursing, 40(4), 323–331. https://doi.org/10.1097/NCC.0000000000000406
Ruiter, M. B., Reneman, L., Boogerd, W., Veltman, D. J., van Dam, F. S., Nederveen, A. J., … Schagen, S. B. (2011). Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Human Brain Mapping, 32(8), 1206–1219. https://doi.org/10.1002/hbm.21102
Scherling, C., Collins, B., MacKenzie, J., Bielajew, C., & Smith, A. (2012a). Prechemotherapy differences in response inhibition in breast cancer patients compared to controls: A functional magnetic resonance imaging study. Journal of Clinical and Experimental Neuropsychology, 34(5), 543–560. https://doi.org/10.1080/13803395.2012.666227
Scherling, C., Collins, B., MacKenzie, J., Bielajew, C., & Smith, A. (2012b). Structural brain differences in breast cancer patients compared to matched controls prior to chemotherapy. International Journal of Biology, 4(2), 3–25 https://doi.org/10.5539/ijb.v4n2p3
Scherling, C. S., Collins, B., MacKenzie, J., Bielajew, C., & Smith, A. (2011). Pre-chemotherapy differences in visuospatial working memory in breast cancer patients compared to controls: An fMRI study. Frontiers in Human Neuroscience, 5. https://doi.org/10.3389/fnhum.2011.00122, Pre-Chemotherapy Differences in Visuospatial Working Memory in Breast Cancer Patients Compared to Controls: An fMRI Study, 5.
Schilder, C. M., Seynaeve, C., Beex, L. V., Boogerd, W., Linn, S. C., & Gundy, C. M. (2010). Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: Results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial. Journal of Clinical Oncology, 28(8), 1294–1300. https://doi.org/10.1200/JCO.2008.21.3553
Schneemilch, C. E., & Schilling, T. B. (2004). Effects of general anaesthesia on inflammation. Best Practice & Research, Clinical Anaesthesiology, 18(3), 493–507. https://doi.org/10.1016/j.bpa.2004.01.002
Shilling, V., & Jenkins, V. (2007). Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. European Journal of Oncology Nursing, 11(1), 6–15. https://doi.org/10.1016/j.ejon.2006.02.005
Silverman, D. H., Dy, C. J., Castellon, S. A., Lai, J., Pio, B. S., Abraham, L., … Ganz, P. A. (2007). Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Research and Treatment, 103(3), 303–311. https://doi.org/10.1007/s10549-006-9380-z
Simó, M., Rifà-ros, X., Rodriguez-Fornells, A., & Bruna, J. (2013). Chemobrain: A systematic review of structural and functional neuroimaging studies. Neuroscience and Biobehavioral Reviews, 37(8), 1–11. https://doi.org/10.1016/j.neubiorev.2013.04.015
Spooner, D., & Pachana, N. (2006). Ecological validity in neuropsychological assessment: A case for greater consideration in research with neurologically intact populations. Archives of Clinical Neuropsychology, 21(4), 327–337. https://doi.org/10.1016/j.acn.2006.04.004
Stouten-Kemperman, M. M., De Ruiter, M. B., Koppelmans, V., Boogerd, W., Reneman, L., & Schagen, S. B. (2015). Neurotoxicity in breast cancer survivors ≥ 10 years post-treatment is dependent on treatment type. Brain Imaging and Behavior, 9(2), 275–284. https://doi.org/10.1007/s11682-014-9305-0
Tao, L., Lin, H., Yan, Y., Xu., X., Wang, L., Zhang, J., & Yu. Y. (2017). Impairment of the executive function in breast cancer patients receiving chemotherapy treatment : A functional MRI study. European Journal of Cancer Care, 26(6). https://doi.org/10.1111/ecc.12553.
Treanor, C. J., McMenamin, U. C., O’Neill, R. F., Cardwell, C. R., Clarke, M. J., Cantwell, M., & Donnelly, M. (2016). Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD011325
van der Werff, S. J., van den Berg, S. M., Pannekoek, J. N., Elzinga, B. M., & van der Wee, N. J. (2013). Neuroimaging resilience to stress: A review. Frontiers in Behavioral Neuroscience, 7, 39. https://doi.org/10.3389/fnbeh.2013.00039
van Dyk, K., Hunter, A. M., Ercoli, L., Petersen, L., Leuchter, A. F., & Ganz, P. A. (2017). Evaluating cognitive complaints in breast cancer survivors with the FACT-cog and quantitative electroencephalography. Breast Cancer Research and Treatment, 166(1), 157–166. https://doi.org/10.1007/s10549-017-4390-6
Von Ah, D., & Jansen, C. E. (2014). Evidence-based interventions for cancer and treatment-related cognitive impairment. Clinical Journal of Oncology Nursing, 18(6), 17–25. https://doi.org/10.1188/14.CJON.S3.17-25
Wefel, J. S., Saleeba, A. K., Buzdar, A. U., & Meyers, C. A. (2010). Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer, 116(14), 3348–3356. https://doi.org/10.1002/cncr.25098
Wefel, J. S., & Schagen, S. (2012). Chemotherapy-related cognitive dysfunction. Current Neurology and Neuroscience Reports, 12(3), 267–275. https://doi.org/10.1007/s11910-012-0264-9
Wefel, J. S., Vardy, J., Ahles, T., & Schagen, S. B. (2011). International cognition and Cancer task force recommendations to harmonise studies of cognitive function in patients with cancer. The Lancet Oncology, 12, 703–708. https://doi.org/10.1016/S1470-2045(10)70294-1,7
Zunini, R. A. L., Scherling, C., Wallis, N., Collins, B., Mackenzie, J., Bielajew, C., & Smith, A. M. (2013). Differences in verbal memory retrieval in breast cancer chemotherapy patients compared to healthy controls: A prospective fMRI study. Brain Imaging and Behavior, 7(4), 460–477. https://doi.org/10.1007/s11682-012-9213-0
Acknowledgements
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors report no conflicts of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 63 kb)
Rights and permissions
About this article
Cite this article
Sousa, H., Almeida, S., Bessa, J. et al. The Developmental Trajectory of Cancer-Related Cognitive Impairment in Breast Cancer Patients: A Systematic Review of Longitudinal Neuroimaging Studies. Neuropsychol Rev 30, 287–309 (2020). https://doi.org/10.1007/s11065-020-09441-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11065-020-09441-9